Amerikanische Gesellschaft für Hirudotherapie

Research progress on processing history evolution, chemical constituents, and pharmacological effects of Hirudo

Research article published in Zhongguo Zhong yao za zhi (2022)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)ArzneimittelentwicklungJiang Q et al. · Zhongguo Zhong yao za zhi, 2022

Abstract

As a traditional animal drug, Hirudo is slightly toxic and has the effects of breaking blood stasis, dredging meridians, expelling stasis, and resolving mass. It has a long history of processing, and the early boiling records can be traced back to the Han Dynasty. More than ten processing methods such as frying, roasting, and lime processing appeared later. After processing, Hirudo is deodorized and modified in taste and becomes crispy, which is conducive to crushing and clinical application. At present, the reported components in Hirudo mainly include protein polypeptides, pteridines, and lipids, which have anti-coagulant, anti-thrombotic, anti-atherosclerotic, anti-tumor, and other pharmacological effects. This study reviewed the processing history evolution, chemical consti-tuents, and pharmacological effects of Hirudo to provide a reference for the related research on Hirudo.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal Article
Indexed MeSH termsAnimalsDrugs, Chinese HerbalEvolution, ChemicalLeechesThrombosisRestraint, Physical

Zusammenfassung

Research progress on processing history evolution, chemical constituents, and pharmacological effects of Hirudo.

Warum dies für die Hirudotherapie relevant ist

This article reviews the processing history, chemical constituents, and pharmacological effects of Hirudo as a traditional animal drug. It traces early boiling records to the Han Dynasty, with frying, roasting, and lime processing appearing later, and notes that processing deodorizes and modifies Hirudo for clinical use. It reports that main constituents—protein polypeptides, pteridines, and lipids—exert anticoagulant, antithrombotic, anti-atherosclerotic, and antitumor effects. The topic is relevant to ASH given its focus on leech-derived bioactive compounds and anticoagulant pharmacology. Caveat: the publication type is an English abstract of a journal article, and it is a review rather than original experimental data.

Zitation

Research progress on processing history evolution, chemical constituents, and pharmacological effects of Hirudo

Jiang Q et al. · Zhongguo Zhong yao za zhi, 2022

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.